Clinical Trial Update: Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Norfloxacin for primary prophylaxis of spontaneous bacterial peritonitis has completed. The study includes patients with cirrhosis, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Norfloxacin (Norfloxacin)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Spontaneous Bacterial Peritonitis, Hepatorenal Syndrome | Phase 4 | Status: COMPLETED